GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026
Globe Newswire•24/08/2026•09:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.